Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 2921-2929, December 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Curtis, J. E.
Right arrow Articles by Freireich, E. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curtis, J. E.
Right arrow Articles by Freireich, E. J

Antigen-specific Immunity in Recipients of Leukocyte Transfusions from Immune Donors1

John E. Curtis, Evan M. Hersh and Emil J Freireich

Department of Developmental Therapeutics, University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas 77025

Adoptive immunity in man has been studied with the primary antigens of keyhole limpet hemocyanin (KLH) and the amino acid copolymer of the L-isomers of glutamic acid, lysine, alanine, and tyrosine (GLAT). Thirteen volunteer donors with chronic lymphocytic leukemia and other malignant diseases were immunized with KLH or GLAT or both. Immune peripheral blood leukocytes were collected with an IBM-NCI blood cell separator. Between 1.1 and 15.6 x 1010 lymphocytes were collected from the chronic lymphocytic leukemia leukocyte donors; from 0.16 to 1.1 x 1010 lymphocytes were collected from the other donors. The leukocyte recipients were all patients with advanced malignant disease. Thirty-one of the 55 recipients evaluated for KLH sensitivity after the transfusion had evidence of immunity as measured by delayed hypersensitivity, antibody formation, or in vitro lymphocyte blastogenesis. Eleven of 13 studied for transfer of GLAT immunity were positive by at least one of the above parameters of immunity. Ten of 46 recipients skin tested were KLH skin test positive, as was 1 of 7 skin tested for GLAT. Ten of 47 and 5 of 13 recipients whose lymphocytes were evaluated for in vitro lymphocyte blastogenesis stimulated by KLH and GLAT, respectively, were positive. Fifty-eight % of 36 recipients evaluated developed KLH antibody, compared with 11 of 13 leukocyte recipients producing GLAT antibody. Leukocytes from both types of donors were equally successful at transferring immunity. Adoptive immunity occurred more frequently in recipients with granulocytic leukemia than in recipients with solid tumors of lymphoma.

1 This work was supported by Grant CA 08859 from the USPHS and Grant CA 05831 from the National Cancer Institute. Presented in part at the 60th Annual Meeting of the American Association for Cancer Research, San Francisco, Calif., 1969.

Received 6/ 5/70. Accepted 8/10/70.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.